NEW YORK (GenomeWeb News) – The formation of the Kinomed Partnership was announced today to provide integrated services for protein kinase inhibitor discovery and development and other research.
The European partnership comprises Iota Pharmaceuticals, protein research firm KinaseDetect, and drug discovery firm SARomics Biostructures.
Other services the partnership is offering include kinase production, kinase assay development, kinase crysal structure determination, kinase fragment library construction, hit finding and optimization, in silico screening, kinase biochemical and biophysical screening, structure- and ligand-based drug design, and medicinal chemistry.
Funding for the partnership comes from the Eurostars program of the European Union.